Literature DB >> 17476495

Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Clarita V Odvina1, Khashayar Sakhaee, Howard J Heller, Roy D Peterson, John R Poindexter, Paulette K Padalino, Charles Y C Pak.   

Abstract

The exact metabolic-physiological background for kidney stone formation in primary hyperparathyroidism (PHPT) is unclear. To obtain clarification, this retrospective data analysis was conducted in 131 patients with PHPT who had undergone a detailed ambulatory evaluation on a random diet since 1980. The baseline biochemical presentation of 78 patients with PHPT with stones was compared with that of 53 patients without stones. Compared to those without stones, the stone-forming patients had a more marked hypercalciuria (343 +/- 148 vs. 273 +/- 148 mg/day, P < 0.01). Urinary saturation of calcium oxalate and brushite was significantly higher in stone-formers. Serum PTH and fasting urinary calcium were similar between the two groups, but serum phosphorus was significantly lower in stone-formers. Serum calcitriol (available in some patients) showed a slightly higher mean value in stone-formers but the difference was not significant. The increment in urinary calcium after oral load of 1-g calcium was twofold higher among stone-formers. Radial shaft and L2-L4 bone mineral densities resided within the normal ranges. Stone-formers with PHPT display exaggerated urinary calcium excretion due to intestinal hyperabsorption of calcium, contributing to a greater enhancement of the saturation of stone-forming calcium salts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476495     DOI: 10.1007/s00240-007-0096-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  18 in total

1.  Calcium intake in patients with primary hyperparathyroidism.

Authors:  C E DENT; B V HARTLAND; J HICKS; E D SYKES
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

2.  A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias.

Authors:  C Y Pak; R Kaplan; H Bone; J Townsend; O Waters
Journal:  N Engl J Med       Date:  1975-03-06       Impact factor: 91.245

3.  Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor.

Authors:  Alfredo Scillitani; Vito Guarnieri; Claudia Battista; Simona De Geronimo; Lucia Anna Muscarella; Iacopo Chiodini; Mauro Cignarelli; Salvatore Minisola; Francesco Bertoldo; Cristiano M Francucci; Nazzarena Malavolta; Alessandro Piovesan; Maria Lucia Mascia; Silvana Muscarella; Geoffrey N Hendy; Leonardo D'Agruma; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

4.  Nephrolithiasis and bone involvement in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; T P Jacobs; E S Siris; F Gartenberg; D Seldin; T L Clemens; J P Bilezikian
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

5.  A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.

Authors:  C Y Pak; M J Nicar; R Peterson; J E Zerwekh; W Snyder
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

6.  Correspondence between stone composition and urine supersaturation in nephrolithiasis.

Authors:  J H Parks; M Coward; F L Coe
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

7.  Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones.

Authors:  J A Söreide; J A van Heerden; C S Grant; C Y Lo; D M Ilstrup
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

8.  The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.

Authors:  A E Broadus; R L Horst; R Lang; E T Littledike; H Rasmussen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

9.  Photon absorptiometric analysis of bone density in primary hyperparathyroidism.

Authors:  C Y Pak; A Stewart; R Kaplan; H Bone; C Notz; R Browne
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

10.  Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.

Authors:  C Y Pak
Journal:  Invest Urol       Date:  1979-09
View more
  18 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Hypercalcemic States associated with nephrolithiasis.

Authors:  Brandon L Craven; Corey Passman; Dean G Assimos
Journal:  Rev Urol       Date:  2008

3.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

4.  Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidism.

Authors:  Hussam Abusahmin; John Geen; Gautam Das
Journal:  Ther Adv Endocrinol Metab       Date:  2018-07-24       Impact factor: 3.565

5.  Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism.

Authors:  C Rowlands; A Zyada; S Zouwail; H Joshi; M J Stechman; D M Scott-Coombes
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

6.  Biochemical evaluation in renal stone disease.

Authors:  Corrado Vitale; Emanuele Croppi; Martino Marangella
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 7.  Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Bridget Sinnott
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

8.  Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.

Authors:  Giuseppe Viccica; Filomena Cetani; Edda Vignali; Mario Miccoli; Claudio Marcocci
Journal:  Endocrine       Date:  2016-03-31       Impact factor: 3.633

Review 9.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

10.  Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.

Authors:  Giuseppe Vezzoli; Alfredo Scillitani; Sabrina Corbetta; Annalisa Terranegra; Elena Dogliotti; Vito Guarnieri; Teresa Arcidiacono; Lorenza Macrina; Alessandra Mingione; Caterina Brasacchio; Cristina Eller-Vainicher; Daniele Cusi; Anna Spada; David E C Cole; Geoffrey N Hendy; Donatella Spotti; Laura Soldati
Journal:  J Nephrol       Date:  2014-05-16       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.